2 min read
Meet Veristat at the ASCO Annual Meeting
May 29 - June 2, 2026 | Chicago, IL
▶️ At the Forefront of Oncology Progress
Veristat is pleased to attend the ASCO...
The European Union Medical Device Regulation’s (MDR) Article 117 brings improved patient safety measures with new implications for manufacturers, as they must fulfill a significant set of additional requirements.
Listen to the full episode on Veristat’s Advancing Revolutionary Therapies Podcast to learn more about the Article and its influence on the marketing of combination products.
Learning Points
- What are Drug Device Combination (DDC) products
- What is Article 117 of the MDR
- The impact of Article 117 on Manufacturers
Meet Veristat. Learn More.
Get the Latest News
Categories
- Regulatory Consulting (135)
- Regulatory Submissions (130)
- Clinical Trial Regulations (119)
- COVID-19 (46)
- Strategic Consulting (40)
- Clinical Trials (35)
- Life At Veristat (21)
- Oncology (18)
- Events (16)
- Success Stories (13)
- Clinical Operations/Monitoring (12)
- Project Management (11)
- Decentralized Trials/Virtual Trials (9)
- Full-Service (9)
- Medical Writing (9)
- CMC (6)
- Data Management (5)
- Marketing Applications (5)
- Adaptive Design (4)
- Neurology/CNS (4)
- Statistics and Programming (4)
- Biologics (3)
- Cell Gene and RNA (3)
- Biometrics (2)
- Natural History (2)
- Psychedelics (2)
- Rare Diseases (2)
- Hematology (1)
- Medical Affairs (1)
1 min read
Connect with Veristat at OCT East Coast
Apr 30, 2026 Veristat Events
May 12-13, 2026 – New Brunswick, NJ
⚛️ Where Clinical Operations Meet Real-World Execution
Veristat is pleased to...